Advertisement
Table 1 The clinico-pathological characteristics of patients with primary operable invasive ductal breast cancer (n = 360)
| Clinico-pathological characteristics | Patients, n (%) |
|---|---|
| Age (≤50/ >50 years) | 125(35%)/235(65%) |
| Size (≤20/ 21-50/ >50 mm) | 185(51%)/162(45%)/13(4%) |
| Grade (I / II / III) | 48(13%)/124(34%)/188(52%) |
| Involved lymph node (-ve/+ve) | 206(57%)/154(43%) |
| ER status (no/yes) | 171(47%)/189(53%) |
| PR status (no/yes) | 194(54%)/166(46%) |
| HER2 status (no/yes) | 289(80%)/71(20%) |
| Triple-negative tumours (no/yes) | 240(67%)/120(33%) |
| Endocrine therapy (no/yes/unknown) | 272(76%)/81(22%)/7(2%) |
| Chemotherapy (no/yes/unknown) | 209(58%)/144(40%)/7(2) |
| Tumour recurrence (no/local/distant/both) | 271(75%)/17(5%)/67(19%)/5(1%) |
| Alive/cancer death/non cancer death | 189(53%)/97(27%)/74(21%) |
